Literature DB >> 33185603

Functional Integrity of Synapses in the Central Nervous System of Cognitively Intact Individuals with High Alzheimer's Disease Neuropathology is Associated with Absence of Synaptic Tau Oligomers.

Ayush Singh1, Dyron Allen1, Anna Fracassi1, Batbayar Tumurbaatar1, Chandramouli Natarajan1, Pietro Scaduto1, Randy Woltjer2, Rakez Kayed1, Agenor Limon1, Balaji Krishnan1, Giulio Taglialatela1.   

Abstract

BACKGROUND: Certain individuals, here referred to as Non-Demented with Alzheimer Neuropathology (NDAN), do not show overt neurodegeneration (N - ) and remain cognitively intact despite the presence of plaques (A+) and tangles (T+) that would normally be consistent with fully symptomatic Alzheimer's disease (AD).
OBJECTIVE: The existence of NDAN (A + T +N - ) subjects suggests that the human brain utilizes intrinsic mechanisms that can naturally evade cognitive decline normally associated with the symptomatic stages of AD (A + T +N +). Deciphering the underlying mechanisms would prove relevant to develop complementing therapeutics to prevent progression of AD-related cognitive decline.
METHODS: Previously, we have reported that NDAN present with preserved neurogenesis and synaptic integrity paralleled by absence of amyloid oligomers at synapses. Using postmortem brain samples from age-matched control subjects, demented AD patients and NDAN individuals, we performed immunofluorescence, western blots, micro transplantation of synaptic membranes in Xenopus oocytes followed by twin electrode voltage clamp electrophysiology and fluorescence assisted single synaptosome-long term potentiation studies.
RESULTS: We report decreased tau oligomers at synapses in the brains of NDAN subjects. Furthermore, using novel approaches we report, for the first time, that such absence of tau oligomers at synapses is associated with synaptic functional integrity in NDAN subjects as compared to demented AD patients.
CONCLUSION: Overall, these results give further credence to tau oligomers as primary actors of synaptic destruction underscoring cognitive demise in AD and support their targeting as a viable therapeutic strategy for AD and related tauopathies.

Entities:  

Keywords:  Alzheimer’s disease; cognitive reserve; electrophysiology; flow cytometry; immunofluorescence; synapses; synaptosomes; tauopathy; western blotting

Year:  2020        PMID: 33185603     DOI: 10.3233/JAD-200716

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  8 in total

1.  Aβ/tau oligomer interplay at human synapses supports shifting therapeutic targets for Alzheimer's disease.

Authors:  Michela Marcatti; Anna Fracassi; Mauro Montalbano; Chandramouli Natarajan; Balaji Krishnan; Rakez Kayed; Giulio Taglialatela
Journal:  Cell Mol Life Sci       Date:  2022-04-04       Impact factor: 9.207

2.  Changes in glial cell phenotypes precede overt neurofibrillary tangle formation, correlate with markers of cortical cell damage, and predict cognitive status of individuals at Braak III-IV stages.

Authors:  Raquel N Taddei; Maria V Sanchez-Mico; Orla Bonnar; Theresa Connors; Angelica Gaona; Dominique Denbow; Matthew P Frosch; Teresa Gómez-Isla
Journal:  Acta Neuropathol Commun       Date:  2022-05-09       Impact factor: 7.578

Review 3.  Peripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer's Disease.

Authors:  Amy R Nelson
Journal:  Front Aging Neurosci       Date:  2022-04-18       Impact factor: 5.702

Review 4.  Lesions without symptoms: understanding resilience to Alzheimer disease neuropathological changes.

Authors:  Teresa Gómez-Isla; Matthew P Frosch
Journal:  Nat Rev Neurol       Date:  2022-03-24       Impact factor: 44.711

5.  Chronic Low Dose Neutron Exposure Results in Altered Neurotransmission Properties of the Hippocampus-Prefrontal Cortex Axis in Both Mice and Rats.

Authors:  Balaji Krishnan; Chandramouli Natarajan; Krystyn Z Bourne; Leila Alikhani; Juan Wang; Allison Sowa; Katherine Groen; Bayley Perry; Dara L Dickstein; Janet E Baulch; Charles L Limoli; Richard A Britten
Journal:  Int J Mol Sci       Date:  2021-04-01       Impact factor: 5.923

6.  Differential protein expression in the hippocampi of resilient individuals identified by digital spatial profiling.

Authors:  Jamie M Walker; Shiva Kazempour Dehkordi; Habil Zare; Miranda E Orr; Anna Fracassi; Alison Vanschoiack; Anna Pavenko; Giulio Taglialatela; Randall Woltjer; Timothy E Richardson
Journal:  Acta Neuropathol Commun       Date:  2022-02-14       Impact factor: 7.801

Review 7.  Synaptic Disruption by Soluble Oligomers in Patients with Alzheimer's and Parkinson's Disease.

Authors:  Berenice A Gutierrez; Agenor Limon
Journal:  Biomedicines       Date:  2022-07-19

Review 8.  Personalizing the Care and Treatment of Alzheimer's Disease: An Overview.

Authors:  Dubravka Svob Strac; Marcela Konjevod; Marina Sagud; Matea Nikolac Perkovic; Gordana Nedic Erjavec; Barbara Vuic; Goran Simic; Vana Vukic; Ninoslav Mimica; Nela Pivac
Journal:  Pharmgenomics Pers Med       Date:  2021-05-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.